Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy.
Obesity Unit, Department of Endocrinology, Hospital das Clínicas, University of São Paulo-Brazil (USP), São Paulo, Brazil. brunohalpern@hotmail.com.|Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO), Rua Mato Grosso 306/1711, CEP 01239-040, São Paulo, SP, Brazil. brunohalpern@hotmail.com.
Bruno
B
Halpern
Obesity Unit, Department of Endocrinology, Hospital das Clínicas, University of São Paulo-Brazil (USP), São Paulo, Brazil.|Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO), Rua Mato Grosso 306/1711, CEP 01239-040, São Paulo, SP, Brazil.|Obesity Department of Brazilian Society of Endocrinology and Metabolism (SBEM), Rio de Janeiro, Brazil.
Cintia
C
Cercato
Obesity Unit, Department of Endocrinology, Hospital das Clínicas, University of São Paulo-Brazil (USP), São Paulo, Brazil.|Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO), Rua Mato Grosso 306/1711, CEP 01239-040, São Paulo, SP, Brazil.|Obesity Department of Brazilian Society of Endocrinology and Metabolism (SBEM), Rio de Janeiro, Brazil.
Marcio C
MC
Mancini
D050110:Bariatric Surgery; D015390:Gastric Bypass; D006801:Humans; D016896:Treatment Outcome; D015431:Weight Loss
Bariatric surgery; Diabetes pharmacotherapy; Diabetes relapse; Diabetes remission; Metabolic surgery; Obesity; Roux-en-Y gastric bypass; Sleeve gastrectomy; Type 2 diabetes; Weight loss